Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
Olema Pharmaceuticals (OLMA) Ownership Overview
21.51% Insiders
8.82% Mutual Funds
0.31% Other Institutional Investors
9.17% ETFs
60.19% Public Companies and Individual Investors
The ownership structure of Olema Pharmaceuticals (OLMA) stock is a mix of institutional, retail, and individual investors. Approximately 18.30% of the company’s stock is owned by Institutional Investors, 21.51% is owned by Insiders, and 60.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 13, 2025 | Bain Capital Life Sciences Investors, Llc >10% Owner | xxxxxxxxxxxxx | $1725000 |
| Dec 17, 2024 | Graham G. Walmsley Director | xxxxxxxxxxxxx | $9460274 |
| Dec 11, 2024 | xxxxxxxxxxxxx | $250456 | |
| Dec 11, 2024 | David C. Myles Ch. Discov. & Non Clin Dev Off | xxxxxxxxxxxxx | $234916 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $145750 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $405336 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1284139 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $7914102 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,503,600 | Insider | 8.05% | 27,352,892 | |
| 4,300,000 | Insider | 6.29% | 21,371,000 | |
| 2,559,775 | Institution | 3.75% | 12,722,082 | |
| 2,077,537 | Institution | 3.04% | 10,325,359 | |
| 2,041,795 | Institution | 2.99% | 10,147,721 | |
| 1,408,875 | Insider | 2.06% | 7,002,109 | |
| 1,354,186 | Institution | 1.98% | 6,730,304 | |
| 961,648 | Institution | 1.41% | 4,779,391 | |
| 886,168 | Insider | 1.30% | 4,404,255 | |
| 766,010 | Insider | 1.12% | 3,807,070 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,077,537 | Institution | 3.04% | 10,325,359 | |
| 739,584 | Institution | 1.08% | 3,675,732 | |
| 449,120 | Institution | 0.66% | 2,232,126 | |
| 388,828 | Institution | 0.57% | 1,932,475 | |
| 330,025 | Institution | 0.48% | 1,640,224 | |
| 309,150 | Institution | 0.45% | 1,536,476 | |
| 270,711 | Institution | 0.40% | 1,345,434 | |
| 234,460 | Institution | 0.34% | 1,165,266 | |
| 219,773 | Institution | 0.32% | 1,092,272 | |
| 184,857 | Institution | 0.27% | 918,739 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,630,966 | Institution | 2.39% | 9,508,532 | |
| 1,101,770 | Institution | 1.61% | 5,475,797 | |
| 871,741 | Institution | 1.28% | 4,210,509 | |
| 591,593 | Institution | 0.87% | 3,448,987 | |
| 336,190 | Institution | 0.49% | 1,670,864 | |
| 272,926 | Institution | 0.40% | 1,356,442 | |
| 194,022 | Institution | 0.28% | 1,131,148 | |
| 180,094 | Institution | 0.26% | 869,854 | |
| 179,339 | Institution | 0.26% | 866,207 | |
| 121,759 | Institution | 0.18% | 588,096 |
FAQ
Who Owns Olema Pharmaceuticals (OLMA)?
According to the latest TipRanks data, approximately 0.31% of the company's stock is held by institutional investors, 21.51% is held by insiders, and 60.19% is held by retail investors.
What percentage of Olema Pharmaceuticals (OLMA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.31% of Olema Pharmaceuticals (OLMA) stock is held by institutional investors.
What percentage of Olema Pharmaceuticals (OLMA) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.19% of Olema Pharmaceuticals (OLMA) stock is held by retail investors.
Who owns the most shares of Olema Pharmaceuticals (OLMA)?
Paradigm Biocapital Advisors LP owns the most shares of Olema Pharmaceuticals (OLMA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.